Work

EML4–ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib

Year: 2018

Type: article

Study design: Case Report

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-018-3571-2

Authors: Thomas Huang, Brigitte J. Engelmann, Rachael M. Morgan, Kimberly J. Absher, Jill M. Kolesar, John L. Villano

Institutions: University of Kentucky, Markey Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2795745467

FWCI: 1.317

Cites: 7

Cited by: 8

Related to: 10